These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21244342)

  • 21. Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.
    Handelsman Y; Goldberg RB; Garvey WT; Fonseca VA; Rosenstock J; Jones MR; Lai YL; Jin X; Misir S; Nagendran S; Abby SL
    Endocr Pract; 2010; 16(4):617-28. PubMed ID: 20634176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucose and low-density lipoprotein cholesterol lowering in elderly patients with type 2 diabetes: focus on combination therapy with colesevelam HCl.
    Marrs JC
    Drugs Aging; 2012 May; 29(5):e1-e12. PubMed ID: 22530704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colesevelam (Welchol) for hypercholesterolemia.
    Med Lett Drugs Ther; 2000 Oct; 42(1091):102-4. PubMed ID: 11056044
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hypercholesterolemia: when statins are not enough or not tolerated. With combination therapy to LDL cholesterol target goal].
    MMW Fortschr Med; 2012 Jul; 154(13):86-7. PubMed ID: 22957390
    [No Abstract]   [Full Text] [Related]  

  • 25. Colesevelam - a bile acid sequestrant for treating hypercholesterolemia and improving hyperglycemia.
    Esan O; Viljoen A; Wierzbicki AS
    Expert Opin Pharmacother; 2022 Aug; 23(12):1363-1370. PubMed ID: 35968655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
    Jialal I; Abby SL; Misir S; Nagendran S
    Metab Syndr Relat Disord; 2009 Jun; 7(3):255-8. PubMed ID: 19344229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemia.
    Florentin M; Liberopoulos EN; Mikhailidis DP; Elisaf MS
    Curr Med Res Opin; 2008 Apr; 24(4):995-1009. PubMed ID: 18291066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colesevelam hydrochloride for the treatment of type 2 diabetes mellitus.
    Sonnett TE; Levien TL; Neumiller JJ; Gates BJ; Setter SM
    Clin Ther; 2009 Feb; 31(2):245-59. PubMed ID: 19302898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Colesevelam hydrochloride: a non-absorbed, polymeric cholesterol-lowering agent.
    Davidson MH; Dicklin MR; Maki KC; Kleinpell RM
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2663-71. PubMed ID: 11060828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of colesevelam hydrochloride in the treatment of dyslipidemia: a review.
    Davidson MH
    Expert Opin Pharmacother; 2007 Oct; 8(15):2569-78. PubMed ID: 17931091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of colesevelam HCl in type 2 diabetes mellitus therapy.
    Handelsman Y
    Postgrad Med; 2009 May; 121(3 Suppl 1):19-24. PubMed ID: 19494474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colesevelam.
    Melian EB; Plosker GL
    Am J Cardiovasc Drugs; 2001; 1(2):141-6; discussion 147-8. PubMed ID: 14728043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetes.
    Handelsman Y; Abby SL; Jin X; Donovan JM; Jones MR
    Postgrad Med; 2009 Nov; 121(6):62-9. PubMed ID: 19940418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of colesevelam HCl in patients with type 2 diabetes mellitus: combining glucose- and lipid-lowering effects.
    Goldfine AB; Fonseca VA
    Postgrad Med; 2009 May; 121(3 Suppl 1):13-8. PubMed ID: 19494473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire.
    Wedlake L; Thomas K; Lalji A; Anagnostopoulos C; Andreyev HJ
    Clin Ther; 2009 Nov; 31(11):2549-58. PubMed ID: 20109999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colesevelam in the treatment of hypercholesterolemia and hyperglycemia: a retrospective analysis from an ambulatory care medical network.
    Romanelli RJ; Leahy A; Jukes T; Ye X; Qian C; Ishisaka DY
    Curr Med Res Opin; 2013 Dec; 29(12):1747-56. PubMed ID: 24024750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colesevelam hydrochloride in the management of dyslipidemia.
    Armani A; Toth PP
    Expert Rev Cardiovasc Ther; 2006 May; 4(3):283-91. PubMed ID: 16716090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower risk of major cardiovascular events associated with adherence to colesevelam HCI.
    Ye X; Qian C; Liu J; St Peter WL
    Pharmacotherapy; 2013 Oct; 33(10):1062-70. PubMed ID: 23798059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.
    Bays H; Rhyne J; Abby S; Lai YL; Jones M
    Curr Med Res Opin; 2006 Nov; 22(11):2191-200. PubMed ID: 17076980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Colesevelam hydrochloride. A product description].
    Raungaard B; Larsen ML
    Ugeskr Laeger; 2005 Mar; 167(11):1271-3. PubMed ID: 15830496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.